Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka atherosclerosis trial (FAST)

Journal of the American College of Cardiology

Volumn 39, Issue 4, 2002, Pages 610-616

  Sawayama, Yasunori ^a   Shimizu, Chie ^a   Maeda, Naoyasu ^a   Tatsukawa, Masafumi ^a   Kinukawa, Naoko ^b   Koyanagi, Samon ^c   Kashiwagi, Seizaburo ^c   Hayashi, Jun ^a,b  

^a General Medicinel   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; PROBUCOL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DEATH; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; JAPAN; LIPOPROTEINS; MALE; MIDDLE AGED; PRAVASTATIN; PROBUCOL; REMISSION INDUCTION; TIME FACTORS; TUNICA INTIMA;

EID: 0037138578     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01783-1     Document Type: Article

References (24)

1. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanism
2. Mortality over a period of 10 years in patients with peripheral arterial disease
3. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial
4. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis: The Asymptomatic Carotid Artery Plaque study
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
7. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study
8. Probucol: Physiological and pharmacological regulation of small intestinal cholesterol synthesis
9. Effects of probucol on homozygous cases of familial hypercholesterolemia
10. Effect of probucol on xanthomata regression familial hypercholesterolemia
11. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
12. Effects of colestipol-niacin therapy on human femoral atherosclerosis
13. HDL metabolism and its role in lipid transport
14. Intimal plus medial thickenss of arterial wall: A direct measurement with ultrasound imaging
15. Plasma triglycerides and lipoprotein(a): Inverse relationship in a hyperlipidemic Italian population
16. The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)
17. Arterial enlargement in the Atherosclerosis Risk In Communities (ARIC) cohort: In vivo quantification of carotid arterial enlargement
18. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
19. Effects of colestipol-niacin therapy on human femoral atherosclerosis
20. Drug control of reverse cholesterol transport
21. Atherosclerosis: An inflammatory disease
22. The pathogenesis of coronary artery disease and the acute coronary syndromes (2)
23. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
24. Inhibition of hypercholesteromia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation